INNOVATE Corp.
VATE
Positions held
Your positionsVATE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $98.22M | Enterprise value | $715.92M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.40 | Beta | 2.45 | Dividend yield | 0.00% |
| Revenue growth | 74.2% | Earnings growth | — | Gross margin | 15.9% | Operating margin | 8.2% |
| Profit margin | -1.5% | ROE | — | ROA | 4.3% | Debt / equity | — |
| Current ratio | 0.44 | Free cash flow | $111.08M | Analyst recommendation | none | Mean target | — |
| 52w high | $21.30 | 52w low | $3.75 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $422M | $365M | $383M | $347M | $242M | — |
| Op margin | 8.2% | 2.7% | 3.7% | 1.8% | 2.0% | — |
| Net income | $10.7M | -$16.8M | -$7.4M | -$8.9M | -$19.8M | — |
| Gross margin | 18.9% | 14.7% | 15.4% | 14.3% | 18.8% | — |
| Gross profit | $79.5M | $53.5M | $58.9M | $49.7M | $45.6M | — |
| Operating income | $34.5M | $10.0M | $14.3M | $6.1M | $4.9M | — |
- Revenue +16% vs prior quarter ($422M vs $365M).
- Gross margin 18.9% (was 14.7% prior quarter).
- Operating margin expanded to 8.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.4B | $1.6B | — |
| Op margin | 2.3% | 3.6% | 1.9% | 0.8% | — |
| Net income | -$60.6M | -$34.6M | -$35.2M | -$35.9M | — |
| Gross margin | 16.0% | 18.9% | 15.2% | 13.5% | — |
| Gross profit | $200M | $209M | $216M | $221M | — |
| Operating income | $28.7M | $40.0M | $26.5M | $13.4M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · INNOVATE Completes DBM Global Sale, Targets Debt Reduction
2026-10-05 · IES Closes $691 Million Acquisition of DBM Global
2026-10-05 · INNOVATE Completes Sale of DBM Global to IES Holdings
2026-10-05 · IES Holdings Completes Acquisition of DBM Global
2026-10-05 · Top Premarket Decliners
2026-09-21 · The Zacks Analyst Blog Highlights AMD, Linde, Amgen and INNOVATE
2026-09-18 · Top Research Reports for AMD, Linde & Amgen
2026-09-02 · INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX
2026-08-29 · Could IES Holdings (IESC) Win Big While INNOVATE (VATE) Bets its Future on Debt Reduction?
2026-08-18 · VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge
2026-08-18 · MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
2026-08-10 · Top Midday Decliners
Price (daily)
Full chart · RSI · MACD · patterns